SEC Form 4 · accession 0001179110-15-010666
IMMUNOGEN INC · IMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Lambert
Officer — Executive Vice President
Period of report
Jul 1, 2015
Accepted (ET)
Jul 2, 2015 · 9:09 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855654
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jul 1, 2015 | M | 3,888 | $3.19 | A | 110,745 | D | |
| Common StockF1 | Jul 1, 2015 | S | 3,888 | $14.344 | D | 106,857 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $3.19 | Jul 1, 2015 | M | 3,888 | D | Jun 8, 2007 | Jun 8, 2016 | Common Stock | 3,888 | 31,112 | D |
Explanation of responses
- F1Weighted average price of shares sold.
- F2The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan executed by the reporting person on February 20, 2015.
- F3Exercisable as to 11,667 shares commencing on June 8, 2007, 11,667 shares commencing on June 8, 2008, and 11,666 shares commencing on June 8, 2009.